Acurx Pharmaceuticals Llc Stock Price Prediction

ACXP Stock  USD 1.15  0.01  0.88%   
As of today, the RSI of Acurx Pharmaceuticals' share price is approaching 35. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Acurx Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

35

 
Oversold
 
Overbought
The successful prediction of Acurx Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Acurx Pharmaceuticals LLC, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Acurx Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.19)
EPS Estimate Current Year
(0.89)
EPS Estimate Next Year
(2.06)
Wall Street Target Price
11.19
EPS Estimate Current Quarter
(0.20)
Using Acurx Pharmaceuticals hype-based prediction, you can estimate the value of Acurx Pharmaceuticals LLC from the perspective of Acurx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Acurx Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Acurx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Acurx Pharmaceuticals after-hype prediction price

    
  USD 1.1  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Acurx Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acurx Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.153.927.69
Details
Naive
Forecast
LowNextHigh
0.020.914.68
Details
2 Analysts
Consensus
LowTargetHigh
11.2212.3313.69
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.22-0.22-0.22
Details

Acurx Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Acurx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Acurx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Acurx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Acurx Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Acurx Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Acurx Pharmaceuticals' historical news coverage. Acurx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.06 and 4.87, respectively. We have considered Acurx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.15
1.10
After-hype Price
4.87
Upside
Acurx Pharmaceuticals is relatively risky at this time. Analysis and calculation of next after-hype price of Acurx Pharmaceuticals LLC is based on 3 months time horizon.

Acurx Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Acurx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acurx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Acurx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.95 
3.80
  0.05 
  0.23 
8 Events / Month
8 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.15
1.10
4.35 
7,600  
Notes

Acurx Pharmaceuticals Hype Timeline

Acurx Pharmaceuticals LLC is presently traded for 1.15. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of -0.23. Acurx is anticipated to decline in value after the next headline, with the price expected to drop to 1.1. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -4.35%, whereas the daily expected return is presently at -0.95%. The volatility of related hype on Acurx Pharmaceuticals is about 1570.3%, with the expected price after the next announcement by competition of 0.92. About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.09. Acurx Pharmaceuticals LLC had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Acurx Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Acurx Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Acurx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Acurx Pharmaceuticals' future price movements. Getting to know how Acurx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Acurx Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AVTEAerovate Therapeutics(0.02)3 per month 2.13  0.13  5.58 (3.86) 19.11 
ADAGAdagene 0.02 5 per month 0.00 (0.06) 8.13 (9.52) 37.93 
ACRVAcrivon Therapeutics, Common 0.1 6 per month 0.00 (0.10) 7.66 (7.65) 22.84 
RZLTRezolute(0.28)7 per month 3.11 (0) 6.80 (5.54) 30.01 
ANTXAN2 Therapeutics(0.03)11 per month 1.86  0.08  3.73 (3.42) 28.03 
ANEBAnebulo Pharmaceuticals 0.03 5 per month 0.00 (0.04) 8.61 (11.48) 76.00 
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.39 (0) 6.27 (5.79) 20.98 
SILOSilo Pharma 0.00 0 per month 0.00 (0.16) 6.31 (10.57) 23.28 
PTIXWProtagenic Therapeutics(0.01)2 per month 18.39  0.04  60.49 (41.67) 159.98 
LUMOLumos Pharma(0.05)6 per month 2.94  0.03  5.95 (5.19) 16.25 
CADLCandel Therapeutics(0.33)10 per month 0.00 (0.08) 6.63 (5.78) 25.71 
PMVPPmv Pharmaceuticals(0.1)3 per month 2.00 (0.03) 3.75 (3.64) 13.98 
MNPRMonopar Therapeutics(2.62)9 per month 7.85  0.13  15.93 (9.50) 653.56 

Acurx Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Acurx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Acurx using various technical indicators. When you analyze Acurx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Acurx Pharmaceuticals Predictive Indicators

The successful prediction of Acurx Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Acurx Pharmaceuticals LLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Acurx Pharmaceuticals based on analysis of Acurx Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Acurx Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Acurx Pharmaceuticals's related companies.
 2021 2024 (projected)
Current Ratio15.712.41
Net Debt To EBITDA0.750.5

Story Coverage note for Acurx Pharmaceuticals

The number of cover stories for Acurx Pharmaceuticals depends on current market conditions and Acurx Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Acurx Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Acurx Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Acurx Pharmaceuticals Short Properties

Acurx Pharmaceuticals' future price predictability will typically decrease when Acurx Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Acurx Pharmaceuticals LLC often depends not only on the future outlook of the potential Acurx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acurx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding12.7 M
Cash And Short Term Investments7.5 M

Additional Tools for Acurx Stock Analysis

When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.